Le Lézard
Classified in: Health
Subjects: NPT, TDS

Lighthouse Guild to Present Alfred W. Bressler Vision Science Symposium and Pisart Seminar


NEW YORK, Sept. 20, 2018 /PRNewswire/ -- Lighthouse Guild, the leading not-for-profit vision and healthcare organization, will present the 2018 Alfred W. Bressler Vision Science Symposium and The Pisart Seminar at The University Club of New York on October 6, 2018, from 8:30am ? 3pm.   

Dr. Botond Roska

Botond Roska, MD, PhD, and Joshua D. Stein, MD, MS, will be recognized for their significant achievements in vision research during a luncheon ceremony.  Dr. Roska is the recipient of the 2018 Alfred W. Bressler Prize, and Dr. Stein is the 2018 Pisart Award honoree.

Alan R. Morse, JD, PhD, President and CEO of Lighthouse Guild, said, "Cost, health literacy, race, socioeconomic status, geography and many other factors contribute to significant disparities in access and outcomes of care.  As a nation we need to do more to address preventable vision loss."  

He added, "As we focus on how we can direct more attention to identifying and addressing eye health, we are pleased to recognize leaders in vision science whose significant research is already making a difference in the lives of people with vision loss. Their work inspires us all."

The Bressler Vision Science Symposium is entitled "Gene Diseases and Gene Therapy of the Retina."  The symposium will be moderated by Frank Werblin, PhD, Professor Emeritus of Neurobiology, Department of Molecular & Cell Biology, University of California, Berkeley.

Dr. Roska, this year's Bressler Prize recipient, will lecture during the symposium on "The First Steps in Vision: Cell Types, Circuits and Repair."  Dr. Roska is the Director of the Institute of Molecular and Clinical Ophthalmology Basel (IOB), Senior Group Leader at the Friedrich Miescher Institute for Biomedical Research, and a Professor at the Faculty of Medicine, University of Basel, Basel, Switzerland.

The Pisart Seminar is led by Pisart Award recipient, Dr. Stein, who will discuss "Tapping into Big Data to Enhance the Care of Patients with Ocular Diseases."  Dr. Stein is an Associate Professor, Department of Ophthalmology and Visual Sciences at the W.K. Kellogg Eye Center, University of Michigan.

Jean Bennett, MD, PhD, who received the Bressler Prize in 2012 will discuss - "From DNA Through FDA: Experiences in Translational Research for Inherited Blindness."  Dr. Bennett is Professor of Ophthalmology, Cell and Developmental Biology, F. M. Kirby Center for Molecular Ophthalmology, Perelman School of Medicine, University of Pennsylvania.

2011 Bressler Prize recipient, Constance L. Cepko, PhD, will discuss "Protecting and Feeding Cones Preserves Vision."  Dr. Cepko is Professor of Genetics, Investigator, Howard Hughes Medical Institute, Department of Genetics, Harvard Medical School.

Other lecturers and topics will include:

Bressler Vision Science Symposium

Pisart Seminar

Bressler Prize Recipient
Dr. Roska has advanced the understanding of how cell types interact in local circuits in the visual system to compute visual information, created insights into the mechanisms of cell-type specific diseases, and designed new therapies for restoring vision in genetic forms of blindness.  The overall objective is to find ways to repair visual dysfunction for patients with retinitis pigmentosa and other diseases of the retina.     

"Dr. Roska is combining different disciplines to expand knowledge of the retina and different stages of visual processing," said Dr. Morse.  "His scientific achievements are powerful, precedent-setting and establish a new standard for retinal research."

"It is an honor to receive this prestigious award from Lighthouse Guild," said Dr. Roska, the recipient of numerous scientific awards and honors and the author of multiple papers.  "As a scientist working with many others, I am committed to creating a link between basic science and medicine by converting our research on retinal processing into effective treatments for patients with retinal diseases." 

The Bressler Prize recognizes an established professional in the field of vision science whose leadership, research and service have resulted in important advancements in the treatment of eye disease or rehabilitation of persons with vision loss and whose further work is expected to contribute significantly.

Pisart Award Recipient
Dr. Stein's research focuses on trends in the use of eye care services, patients' access to eye care services, patient outcomes after ocular surgery, the cost-effectiveness of different ocular interventions, and the quality of life of patients with ocular diseases.  He uses large databases ("big data") with the goal of improving patients' access to care and improving the quality and value of the eye care patients receive.  He also works to reduce racial and other disparities in eye care among different population groups.

"Dr. Stein is a pioneering vision researcher, whose findings have practical implications for clinical care, patient rehabilitation, and decision-making on how to best allocate limited eye care resources and improve access to eye care services," said Dr. Morse.

The recipient of numerous awards and grants and a prolific author in his field,

Dr. Stein said, "It is a great privilege to receive this prestigious award from Lighthouse Guild, given the organization's unparalleled commitment to preventing vision-threatening eye diseases and improving the lives of patients with compromised sight.  I look forward to continuing to work with my colleagues to advance this important mission."

The Pisart Award recognizes early-career vision clinicians or scientists whose noteworthy, innovative and scholarly contributions have the potential for substantial influence in the understanding of vision loss, treatment of eye disease or the rehabilitation of people with vision loss.

About Lighthouse Guild
Lighthouse Guild is the leading organization dedicated to addressing and preventing vision loss. For more information, visit http://www.LighthouseGuild.org.

Dr. Joshua D. Stein

SOURCE Lighthouse Guild


These press releases may also interest you

at 11:25
TimelyCare, higher education's most trusted virtual health and well-being provider, has earned recognition as one of the World's Best Digital Health Companies by Newsweek, and has been awarded five Top Workplaces Awards for culture excellence....

at 11:16
Avanos Medical, Inc. will webcast its conference call discussing financial results and business highlights for the first quarter 2024 on Thursday, May 2 at 9 a.m., ET. The company will issue a news release detailing its results before the market...

at 11:15
Beijing Avistone Biotechnology Co., Ltd. (also referred to as Avistone Biotechnology or Avistone), an innovative biotechnology company focused on precision oncology therapeutics, announced the approval to expand the use of vebreltinib (also referred...

at 11:10
Through its 2030 Strategic Plan, NJII plans to double the size of the organization and to exceed $70M revenue as it rolls out various new initiatives focused on accelerating technology translation, spurring innovation and upskilling workers. As...

at 11:09
ScreenPoint Medical, today announced a significant transition in its leadership as Mark Koeniguer, the current CEO, steps down from his position. Mark served as CEO since 2022 and was instrumental in ScreenPoint's commercial growth and success over...

at 11:05
With a goal to better inform health care workers about weapons of mass destruction, the Emergency Nurses Association and FBI recently partnered to launch the Bureau's "ABCs on WMDs" podcast series on the association's website....



News published on and distributed by: